Laporan Penyelidikan Pasaran tentang Manik Magnet Isih Sel

Tinjauan Pasaran

Cell sorting magnetic beads are critical tools in biomedical research and cell therapy, with rapid market growth in recent years. The global magnetic beads market reached USD 3.89 bilion dalam 2024 and is projected to exceed USD 16.01 bilion oleh 2037, growing at a compound annual growth rate (CAGR) daripada 11.5%. Cell sorting beads account for 10–15% of the total cost in CAR-T cell therapy production. Namun begitu, habis 95% of the market is dominated by international players like Miltenyi Biotec and Thermo Fisher, while Chinese domestic companies remain in the technological catch-up phase.  

Aplikasi Utama

CAR-T Cell Therapy: Used for high-purity T-cell isolation, mencapai lebih 99% CD3cell purity post-sorting (cth., CD3cell ratio reduced from 36.5% kepada 0.7% in clinical cases).

Immunology Research: Sorting immune cells (B cells, NK cells) via antigen-specific magnetic labeling.

Stem Cell Therapy: Isolation of hematopoietic stem cells and mesenchymal stem cells for regenerative medicine.

In Vitro Diagnostics(IVD): Rapid enrichment of circulating tumor cells (CTCs) or pathogens. Pemacu Pasaran  

Growth of Cell Therapy: Expanding CAR-T therapy commercialization drives demand, with magnetic beads constituting 10–15% of production costs.

Precision Medicine: High-purity cell isolation is essential for single-cell sequencing and personalized therapies.

Localization Trends: Chinese companies like GenScript offer GMP-grade CytoSinct™ beads at 20–30% lower prices than imports, supported by policies promoting domestic alternatives. Technology Advancements: Nano-sized beads (50–70 nm) with high antibody conjugation efficiency and superparamagnetic properties are mainstream.

Competitive Landscape

International Leaders: Miltenyi Biotec, Thermo Fisher, and BD control over 90% of the high-end market with end-to-end solutions.

Domestic Players: Companies like GenScript and Beaver Biosciences focus on cost-effective mid-to-low-end markets. GenScript’s beads are used in CAR-T clinical trials.

Technical Challenges: Key barriers include bead size uniformity, antibody conjugation efficiency, and batch consistency. Domestic firms face hurdles in scaling nano-bead production.

Tinjauan Masa Depan

The cell sorting magnetic beads market is expected to grow at over 12% CAGR from 2025 kepada 2030, driven by cell and gene therapy expansion. Chinese companies may achieve over 30% import substitution in 3–5 years, particularly in GMP-grade bead production, supported by policies like the 14th Five-Year Plan for biopharma innovation.  

Pembekal

Shanghai Lingjun Biotechnology Co., Ltd.ditubuhkan pada 2016 yang merupakan pengilang profesional bahan biomagnet dan reagen pengekstrakan asid nukleik.

Kami mempunyai pengalaman yang kaya dalam pengekstrakan dan penulenan asid nukleik, penulenan protein, pemisahan sel, chemiluminescence, dan bidang teknikal yang lain.

Produk kami digunakan secara meluas dalam pelbagai bidang, seperti ujian perubatan, ujian genetik, penyelidikan universiti, pembiakan genetik, dan seterusnya. Kami bukan sahaja menyediakan produk tetapi juga boleh menjalankan OEM, ODM, dan keperluan lain. Jika anda mempunyai keperluan yang berkaitan, sila hubungi kami .